One of the most fundamental ways for scientists to learn about Parkinson’s disease (PD)...see more
Let’s talk about brain donation
APDA ANNOUNCES $1.7 MILLION IN NEW PARKINSON’S DISEASE RESEARCH GRANTS. FUNDING ENABLES 10 RESEARCHERS TO CONDUCT IMPACTFUL RESEARCH.
APDA announces funding for 2019-2020 grants It is that time of year – when APDA announces our research grantees...see more
New medication, Istradefylline, gets approved for Parkinson’s disease
On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval...see more
APDA Seed Funding Leads to Prestigious NIH Research Grant
APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research...see more
APDA-funded research finds new role for alpha-synuclein
This new understanding of alpha-synuclein’s function could open up new ways of thinking...see more
Fighting Parkinson’s Disease Around the World – Highlights from the World Parkinson Congress
APDA was in Kyoto for the 5th...see more
Menopause & PD: An Interview with APDA Researcher Dr. Roberta Marongiu
Menopause & PD: An Interview with APDA Researcher Dr. Roberta Marongiu Pre-menopausal women have a reduced risk of developing PD...see more
APDA’s Diversity in Parkinson’s Disease Research Conference 2019
APDA held the first Diversity in Parkinson’s Disease Research Conference. on 5/17/19...see more
American Academy of Neurology Annual Meeting 2019 – Highlights
American Academy of Neurology Annual Meeting 2019 - Highlights Our team shares 12 highlights related to Parkinson’s research from the...see more
Alpha-synuclein – then and now, with Dr. Alice Lazzarini
Alpha-synuclein – then and now, with guest blogger, Dr. Alice Lazzarini Renowned researcher Alice Lazzarini, PhD chronicles the connection between...see more